Clinical Research Directory
Browse clinical research sites, groups, and studies.
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
Sponsor: University of California, Los Angeles
Summary
This randomized controlled trial compares two common medications, labetalol and extended-release nifedipine, to determine which is more effective at managing postpartum high blood pressure. We hypothesize that extended-release nifedipine will better control blood pressure and reduce the need for continued medication beyond six weeks postpartum. The study will enroll 110 postpartum participants, randomly assigning them to one of the two medications, with remote blood pressure monitoring to evaluate treatment effectiveness and inform postpartum hypertension management.
Official title: Postpartum Evaluation of Antihypertensive Cessation and Efficacy (PEACE): A Randomized Controlled Trial Comparing Oral Labetalol and Oral Extended-Release Nifedipine for Managing Postpartum Hypertension
Key Details
Gender
FEMALE
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
110
Start Date
2025-04-01
Completion Date
2025-10-31
Last Updated
2025-04-08
Healthy Volunteers
No
Conditions
Interventions
Labetalol
Labetalol is a beta-blocker commonly used to manage hypertension in pregnancy and postpartum. In this study, oral labetalol will be initiated at 200mg twice or three times daily and adjusted up to 2400 mg/day as needed for blood pressure control.
Nifedipine
Nifedipine is a calcium channel blocker commonly used to manage hypertension in pregnancy and postpartum. In this study, oral extended-release nifedipine will be initiated at 30mg once daily and adjusted up to 120mg/day as needed for blood pressure control.